seed
Stage
1
Investors
About
Kyan is a Singapore-headquartered precision medicine biotechnology company that uses artificial intelligence and computational modeling to identify personalized cancer drug combinations and dosing strategies by analyzing tumor genetics, patient characteristics, and treatment responses.
Explore Kyan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.